CCND1 and cancer: CCND1 expression was found to differ significantly between normal and malignant tissues in all stages of COAD, ESCA, KIRC, READ, STAD, and THCA, according to our pan-cancer research, suggesting that CCND1 may be used as a diagnostic biomarker in these types of cancer.